150 related articles for article (PubMed ID: 27567989)
21. [Analysis of serum protein fingerprints on non-small cell lung cancer lymphatic metastasis].
Lü C; Shen J; Wu N; Zheng QF; Wang J; Yan S; Feng Y; Yang Y
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2481-5. PubMed ID: 20137435
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement.
Sakao Y; Miyamoto H; Oh S; Takahashi N; Sakuraba M
J Thorac Oncol; 2007 Dec; 2(12):1107-11. PubMed ID: 18090583
[TBL] [Abstract][Full Text] [Related]
23. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and prognostic factors of node-negative non-small cell lung cancer larger than 5 cm.
Cho S; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):448-454. PubMed ID: 28575399
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
27. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Two Proposed Changes to the Current Nodal Classification for Non--small Cell Lung Cancer Based on the Number and Ratio of Metastatic Lymph Nodes.
Li F; Yuan L; Zhao Y; Wang S; Lv Z; Mao Y
Chest; 2021 Oct; 160(4):1520-1533. PubMed ID: 34029562
[TBL] [Abstract][Full Text] [Related]
29. Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study.
Li H; Sun Z; Yang F; Sui X; Liu T; Wang J
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1121-1129. PubMed ID: 30726889
[TBL] [Abstract][Full Text] [Related]
30. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
[TBL] [Abstract][Full Text] [Related]
31. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
Cerfolio RJ; Bryant AS; Eloubeidi MA
Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of the current Japanese nodal classification on outcomes in resected non-small cell lung cancer.
Ichinose J; Murakawa T; Hino H; Konoeda C; Inoue Y; Kitano K; Nagayama K; Nitadori JI; Anraku M; Nakajima J
Chest; 2014 Sep; 146(3):644-649. PubMed ID: 24811857
[TBL] [Abstract][Full Text] [Related]
33. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and Predictive Effects of Positive Lymph Node Number or Ratio in NSCLC.
Ding N; Pang Z; Zhang X; Huang C; Yang Y; Liu Q; Du J
Sci Rep; 2017 Apr; 7(1):584. PubMed ID: 28373661
[TBL] [Abstract][Full Text] [Related]
35. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
[TBL] [Abstract][Full Text] [Related]
36. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
Asamura H; Chansky K; Crowley J; Goldstraw P; Rusch VW; Vansteenkiste JF; Watanabe H; Wu YL; Zielinski M; Ball D; Rami-Porta R;
J Thorac Oncol; 2015 Dec; 10(12):1675-84. PubMed ID: 26709477
[TBL] [Abstract][Full Text] [Related]
37. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of clinical N0 metastatic non-small cell lung cancer.
Tamura T; Kurishima K; Watanabe H; Shiozawa T; Nakazawa K; Ishikawa H; Satoh H; Hizawa N
Lung Cancer; 2015 Jul; 89(1):71-5. PubMed ID: 25913230
[TBL] [Abstract][Full Text] [Related]
39. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
